Internal Medicine NewsGastric cancer: Family history–based H. pylori strategy would be cost effectiveSeptember 23, 2021GastroenterologyOncology
Internal Medicine NewsDatopotamab deruxtecan for advanced NSCLC encouraging so farSeptember 23, 2021Oncology
Internal Medicine NewsTULIP trial shows extended survival in HER2+ metastatic breast cancerSeptember 23, 2021Breast CancerOncology
Internal Medicine NewsctDNA may be a better surrogate for survival than RECISTSeptember 23, 2021Oncology
Internal Medicine NewsWatchful waiting in BCC: Which patients can benefit?September 22, 2021DermatologyOncology
Internal Medicine NewsNeoadjuvant immunotherapy for resectable head and neck cancer holds therapeutic benefitSeptember 22, 2021Oncology
Internal Medicine NewsStudy supports add-on therapy for germline and wildtype BRCA mutationsSeptember 22, 2021Breast CancerOncology
Internal Medicine NewsNivo/ipi combo now ‘standard of care’ in mesotheliomaSeptember 22, 2021Oncology
Internal Medicine NewsMost community-based oncologists skip biomarker testingSeptember 21, 2021Oncology
Internal Medicine NewsTwelve-month overall survival benefit with ribociclib for metastatic breast cancerSeptember 21, 2021Breast CancerOncology
Internal Medicine NewsCall for a move or boycott of big Texas cancer meetingSeptember 21, 2021Breast CancerOncology
Internal Medicine NewsPatients panic as docs cut off breast cancer drugSeptember 20, 2021Breast CancerOncology
Internal Medicine NewsFlurry of cancer drug endorsements from EU panelSeptember 20, 2021Breast CancerOncology
Internal Medicine NewsFDA approves first oral drug for NSCLC with EGFR Exon 20 insertionSeptember 20, 2021Oncology
Internal Medicine NewsImmunotherapy for cancer patients with poor PS needs a rethinkSeptember 20, 2021Breast CancerOncology
